Insulin-like growth factor-1 sustains stem cell-mediated renal repair

Barbara Imberti, Marina Morigi, Susanna Tomasoni, Cinzia Rota, Daniela Corna, Lorena Longaretti, Daniela Rottoli, Federica Valsecchi, Ariela Benigni, Jun Wang, Mauro Abbate, Carla Zoja, Giuseppe Remuzzi

Research output: Contribution to journalArticlepeer-review


In mice with cisplatin-induced acute kidney injury, administration of bone marrow-derived mesenchymal stem cells (MSC) restores renal tubular structure and improves renal function, but the underlying mechanism is unclear. Here, we examined the process of kidney cell repair in co-culture experiments with MSC and cisplatin-injured proximal tubular epithelial cells (PTEC). Exposure of PTEC to cisplatin markedly reduced cell viability at 4 days, but co-culture with MSC provided a protective effect by promoting tubular cell proliferation. This effect was mediated by insulin-like growth factor-1 (IGF-1), highly expressed by MSC as mRNA and protein, since blocking the growth factor's function with a specific antibody attenuated cell proliferation of PTEC. Confirming this, knocking down IGF-1 expression in MSC by small interfering-RNA also resulted in a significant decrease in PTEC proliferation and increased apoptosis. Furthermore, in the murine model of cisplatin-induced kidney injury, administering IGF-1 gene-silenced MSC limited their protective effect on renal function and tubular structure. These findings indicate that MSC exert beneficial effects on tubular cell repair in acute kidney injury by producing the mitogenic and pro-survival factor IGF-1.

Original languageEnglish
Pages (from-to)2921-2928
Number of pages8
JournalJournal of the American Society of Nephrology
Issue number11
Publication statusPublished - Nov 2007

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Insulin-like growth factor-1 sustains stem cell-mediated renal repair'. Together they form a unique fingerprint.

Cite this